AzTrials
AzTrials

Anesthesia, LocalNCT03130855

Comparison Between Efficiency of Inferior Alveolar Nerve Block and Buccal Infiltration Techniques Using Articaine 4% 1:100000

A study testing inferior alveolar nerve block with 4% articaine and buccal infiltration with 4% articaine in people with Anesthesia, Local, run by Cairo University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This split mouth randomized control trial is designed as to compare the effectiveness of the buccal infiltration technique with the gold standard inferior alveolar nerve block in anesthetizing mandibular second primary molars to undergoing pulpal treatment. Read more about this study

Who is it for?
Ages 6 to 8 yearsHealthy volunteers can take part
Conditions the study is for
Anesthesia, Local
What is being tested?
inferior alveolar nerve block with 4% articaine and buccal infiltration with 4% articaine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
48 participants
Where
No sites listed yet
Study dates
15 May 2017to 1 Aug 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 8 years
  • All sexes
  • Healthy volunteers accepted
  • Child

A-Inclusion Criteria:

  1. first dental visit.
  2. cooperative children (rating 4 or 3 based on Frankl behavior scale) aging from 6 to 8 years suffering from one or more deep carious lesions in their primary molars seeking treatment.
  3. Restorable molars with stainless steel crowns.

B-Exclusion Criteria:

  1. medically compromised patients. uncooperative children (rating 1 or 2 on the Frankl behavior scale)needing special line of treatment through general anesthesia.
  2. signs and symptoms of irreversible pulpitis, spontaneous pain, necrosis or any signs or symptoms of any infection.
  3. presence of any radiographic signs of abcess, bone loss, internal or external root resorption.
  4. parents or guardians who refuse participating in the study.

Trial locations and contacts

No sites are listed yet.

omar sherif abo el abbas, bachelor contact

01210965669

omarsherif15@yahoo.com

hany mohamed saber, lecturer contact

01225519667

drhanysaber@yahoo.com

About this study

Official title: Buccal Infiltration Technique Compared to Inferior Alveolar Nerve Block Technique for Alleviation of Intraoperative Pain During Pulpal Treatment of Mandibular Primary Molars: A Randomized Controlled Clinical Trial.

This split mouth randomized control trial is designed as to compare the effectiveness of the buccal infiltration technique with the gold standard inferior alveolar nerve block in anesthetizing mandibular second primary molars to undergoing pulpal treatment.

patient will be videotaped during pulpal treatment of their teeth and an accessing pain will be through an objective pain scale (SEM scale), (sound-eye-motor scale).

the patient will be asked to fill in a subjective Wong Baker pain scale for the pain suffered during injecting the local anesthetic agent in both techniques.

Being tested
inferior alveolar nerve block with 4% articaine, buccal infiltration with 4% articaine
Keywords
pediatric patients, articaine local anesthesia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • inferior alveolar nerve block with 4% articaineDrug

    an anesthetic technique using 4% articaine anesthetic solution

  • buccal infiltration with 4% articaineDrug

    anesthetic technique using 4% articaine anesthetic solution

Study groups in NCT03130855
Study groupRoleWhat they receive
inferior alveolar nerve block with 4% articaineExperimentalinferior alveolar nerve block using 4% articaine anesthetic solution
Receives: Drug: inferior alveolar nerve block with 4% articaine
buccal infiltration with 4% articaineActive comparatorbuccal infiltration using 4% articaine anesthetic solution
Receives: Drug: buccal infiltration with 4% articaine

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. pain experienced by child during pulpal treatment

    sound-eye-motor

    Measured: one week

Secondary outcomes (2)
  1. time needed for numbness

    stop watch

    Measured: one week

  2. pain experienced by the child due to needle prick

    Wong Baker facial pain scale

    Measured: one week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Apr 2017
  2. Study start15 May 2017 (estimated)
  3. Primary completion1 Jul 2017 (estimated)
  4. Study completion1 Aug 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
48 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03130855
Sponsor's protocol ID
articaine
Status last verified
May 2017
First submitted
2 Apr 2017
Last updated
10 May 2017
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing inferior alveolar nerve block with 4% articaine and buccal infiltration with 4% articaine in people with Anesthesia, Local, run by Cairo University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 10 May 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact omar sherif abo el abbas, bachelor (01210965669, omarsherif15@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

pain experienced by child during pulpal treatment (time frame: one week). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 May 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in